V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20211362 | 20128457 | 1.63 | 70 | null | null | 2018-10-11 | ECX | 02 | null | ECX | 100788513 |
| 20211378 | 20128459 | 1.59 | 47 | Curative (C) | 2019-05-01 | 2019-05-01 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100994968 |
| 20211380 | 20128460 | 1.67 | 80.15 | Palliative (P) | 2019-04-03 | 2019-04-03 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100113657 |
| 20211389 | 20128461 | 1.75 | null | null | 2019-10-12 | 2020-02-11 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 100231399 |
| 20211392 | 20128462 | 1.84 | null | null | 2019-06-09 | 2019-06-11 | null | 02 | null | PANITUMUMAB | 100972523 |
| 20211406 | 20128463 | 1.78 | 55.3 | Palliative (P) | 2018-01-14 | 2018-01-25 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100174025 |
| 20211423 | 20128464 | null | 82.8 | null | null | 2019-10-17 | null | 2 | null | PANITUMUMAB | 100295729 |
| 20211426 | 20128465 | 1.74 | 50.8 | null | 2020-02-14 | 2020-02-22 | CARBOPLATIN + ETOPOSIDE | N | Y | CARBOPLATIN + ETOPOSIDE | 101605017 |
| 20211429 | 20128466 | 1.59 | null | Neo-adjuvant (N) | 2018-08-08 | 2018-12-08 | null | 02 | N | NIVOLUMAB | 100846687 |
| 20211431 | 20128467 | 1.75 | 70 | null | 2020-01-17 | 2020-01-20 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101378731 |
| 20211447 | 20128468 | 1.79 | 76 | Curative (C) | 2020-10-21 | 2020-11-19 | ECX | 2 | N | ECX | 101795480 |
| 20211451 | 20128469 | null | 91 | Palliative (P) | 2016-11-17 | 2017-05-14 | null | 02 | N | NIVOLUMAB | 101858616 |
| 20211452 | 20128470 | 1.75 | null | null | 2018-03-10 | 2018-03-26 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100135415 |
| 20211472 | 20128473 | null | 91 | Palliative (P) | 2016-09-11 | 2016-09-16 | NIVOLUMAB | 2 | N | NIVOLUMAB | 101760521 |
| 20211488 | 20128475 | 1.95 | 65.7 | null | 2019-10-13 | 2020-02-27 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101119237 |
| 20211490 | 20128476 | 1.77 | 80 | Neo-adjuvant (N) | 2017-09-07 | 2017-09-11 | CARBOPLATIN + ETOPOSIDE | 02 | N | PANITUMUMAB | 100866943 |
| 20211498 | 20128478 | null | 70.3 | Neo-adjuvant (N) | 2016-07-08 | 2016-07-21 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100301450 |
| 20211510 | 20128479 | 1.51 | null | Palliative (P) | 2016-05-23 | 2018-05-05 | Panitumumab | 02 | N | PANITUMUMAB | 101165116 |
| 20211515 | 20128480 | 1.93 | 85.1 | Palliative (P) | 2020-11-15 | 2020-11-16 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100013977 |
| 20211527 | 20128481 | 1.72 | null | Palliative (P) | 2017-10-15 | 2018-06-04 | null | N | N | CISPLATIN + FLUOROURACIL | 100857912 |
| 20211552 | 20128483 | 1.85 | 95.6 | Neo-adjuvant (N) | 2017-05-16 | 2017-06-12 | null | 02 | N | CISPLATIN + FLUOROURACIL | 100342809 |
| 20211556 | 20128484 | 1.78 | 77.7 | Neo-adjuvant (N) | 2016-12-14 | 2017-07-27 | Cisplatin +Fluorouracil (2 wk) | 2 | N | CISPLATIN + FLUOROURACIL | 100087176 |
| 20211560 | 20128485 | 1.65 | 83 | Curative (C) | 2019-04-15 | 2019-04-25 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101062134 |
| 20211568 | 20128486 | 1.75 | 65.2 | Curative (C) | 2020-04-01 | 2020-04-01 | ECX | N | N | ECX | 100686963 |
| 20211570 | 20128487 | 1.77 | 55.95 | Curative (C) | 2020-08-14 | 2020-09-02 | Panitumumab | N | null | PANITUMUMAB | 100878858 |
| 20211571 | 20128488 | 1.78 | null | Adjuvant (A) | 2016-09-16 | 2016-11-25 | null | null | N | CISPLATIN + FLUOROURACIL | 101839357 |
| 20211573 | 20128489 | 1.76 | 71.8 | null | 2019-09-05 | 2019-09-05 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100614483 |
| 20211583 | 20128490 | 1.62 | 66.4 | Palliative (P) | 2018-03-28 | 2018-03-28 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 101045102 |
| 20211588 | 20128491 | 1.76 | 42 | null | null | 2018-06-10 | null | 02 | N | NIVOLUMAB | 101367744 |
| 20211594 | 20128492 | null | null | Curative (C) | 2018-04-15 | 2018-05-04 | NIVOLUMAB | 02 | Y | NIVOLUMAB | 100745505 |
| 20211598 | 20128493 | 1.75 | 80 | Adjuvant (A) | 2017-04-05 | 2017-05-24 | ECX | N | Y | ECX | 101211617 |
| 20211601 | 20128494 | 1.73 | 100.6 | Palliative (P) | 2020-10-02 | 2020-10-02 | null | null | N | CARBOPLATIN + ETOPOSIDE | 100041671 |
| 20211605 | 20128495 | 1.66 | null | Curative (C) | 2020-06-06 | 2020-06-13 | CISPLATIN + FLUOROURACIL | N | N | CISPLATIN + FLUOROURACIL | 100103960 |
| 20211618 | 20128498 | 1.7 | null | Palliative (P) | 2019-06-18 | 2019-07-03 | CARBOPLATIN + ETOPOSIDE | 02 | N | CARBOPLATIN + ETOPOSIDE | 101176009 |
| 20211626 | 20128500 | 1.78 | 130.2 | null | 2017-05-25 | 2017-06-15 | ECX | N | N | ECX | 101565646 |
| 20211631 | 20128502 | 1.67 | 66.4 | Curative (C) | 2019-11-07 | 2019-11-07 | ECX | 02 | N | ECX | 101574673 |
| 20211662 | 20128507 | 1.67 | 88.6 | Disease modification (D) | 2017-05-26 | 2017-06-17 | null | 02 | N | NIVOLUMAB | 100934687 |
| 20211665 | 20128508 | 1.81 | 61.4 | null | 2020-01-30 | 2020-02-09 | ECX | 2 | null | ECX | 100144285 |
| 20211673 | 20128509 | 1.77 | 51.2 | Palliative (P) | 2017-01-13 | 2017-02-15 | Panitumumab | N | N | PANITUMUMAB | 100408345 |
| 20211675 | 20128510 | 1.69 | 53.2 | Palliative (P) | 2018-10-29 | 2018-11-21 | ECX | 02 | N | ECX | 101557749 |
| 20211683 | 20128511 | 1.65 | null | Curative (C) | 2020-09-19 | 2020-09-29 | CARBOPLATIN + ETOPOSIDE | N | N | CARBOPLATIN + ETOPOSIDE | 101380847 |
| 20211694 | 20128513 | 1.61 | 59.1 | null | 2018-08-26 | 2018-09-07 | null | 02 | N | NIVOLUMAB | 100790072 |
| 20211695 | 20128514 | 1.67 | 76.3 | Adjuvant (A) | 2016-04-12 | 2016-04-12 | ECX | 02 | N | ECX | 101692068 |
| 20211699 | 20128515 | 1.66 | 55 | null | 2018-04-11 | 2018-04-20 | Panitumumab | 02 | N | PANITUMUMAB | 100387519 |
| 20211716 | 20128517 | null | 60.74 | Neo-adjuvant (N) | 2018-08-15 | 2019-04-20 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100013165 |
| 20211729 | 20128519 | 1.65 | 56 | null | null | 2017-07-05 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100070495 |
| 20211733 | 20128520 | 1.58 | 58.3 | Curative (C) | 2016-05-21 | 2016-05-21 | Panitumumab | 02 | N | PANITUMUMAB | 100448682 |
| 20211742 | 20128521 | 1.7 | null | null | 2015-09-24 | 2017-04-26 | Panitumumab | 02 | N | PANITUMUMAB | 101302799 |
| 20211743 | 20128522 | 1.67 | 50.6 | null | 2017-04-08 | 2017-04-12 | Panitumumab | 02 | null | PANITUMUMAB | 100330718 |
| 20211768 | 20128525 | 1.81 | null | Curative (C) | 2018-04-04 | 2018-05-13 | null | 02 | N | PANITUMUMAB | 101404871 |